← Leaderboards
Jacki Kornbluth
St. Louis Va Medical Center
$741,122
Attributed
$741,122
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $399.6K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$741,122 · 3
VA$0 · 2
By mechanism
R41$399,580 · 1
R56$337,500 · 1
P41$4,042 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at St. Louis Va Medical Center
Same institution · by research overlap
Others in their field
Top investigators on “Membrane”
- Dennis R. Burton · Scripps Research Institute$258,610,184
- Barton F Haynes · Duke University$123,162,119
- Ted Ross · University Of Georgia$71,962,304
- Robert M Stroud · University Of California, San Francisco$63,701,163
- Dennis L. Kasper · Harvard Medical School$58,511,900
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$56,839,058
Research focus
MembraneNeoplastic CellIn VitroNatural Killer CellsPreventTumorCellsApoptosisGenesIn VivoMediatingVeteransNeoplasm MetastasisGrowthProteinsResistanceCell DeathCytokineCell KillingImmune ResponseAntimicrobialHealthcare SystemsLaboratoriesEffector Cell
Grant awards (14)
Molecular Characterization of Anti-Tumor Activity Mediated by Extracellular Vesicles Derived from Natural Killer Cells$0
I01 · FY2025 · VA · contact PI
Molecular Characterization of Anti-Tumor Activity Mediated by Extracellular Vesicles Derived from Natural Killer Cells$0
I01 · FY2024 · VA · contact PI
Molecular Characterization of Anti-Tumor Activity Mediated by Extracellular Vesicles Derived from Natural Killer Cells$0
I01 · FY2023 · VA · contact PI
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer$399,580
R41 · FY2022 · CA · contact PI
NKLAM: An RBR E3 Ubiquitin Ligase Essential for Regulation of Innate Immunity$0
I01 · FY2020 · VA · contact PI
NKLAM: An RBR E3 Ubiquitin Ligase Essential for Regulation of Innate Immunity$0
I01 · FY2019 · VA · contact PI
NKLAM: An RBR E3 Ubiquitin Ligase Essential for Regulation of Innate Immunity$0
I01 · FY2018 · VA · contact PI
NKLAM: An RBR E3 Ubiquitin Ligase Essential for Regulation of Innate Immunity$0
I01 · FY2017 · VA · contact PI
Analysis of NKLAM: A Novel Gene Associated With Cellular Cytotoxicity$0
I01 · FY2015 · VA · contact PI
Analysis of NKLAM: A Novel Gene Associated With Cellular Cytotoxicity$0
I01 · FY2014 · VA · contact PI
Analysis of NKLAM: A Novel Gene Associated With Cellular Cytotoxicity$0
I01 · FY2013 · VA · contact PI
Analysis of NKLAM: A Novel Gene Associated With Cellular Cytotoxicity$0
I01 · FY2012 · VA · contact PI
PLATELET-ACTIVATING FACTOR AND METASTASIS: CALCIUM-INDEPENDENT PHOSPHOLIPASE$4,042
P41 · FY2011 · RR · contact PI
Role of Natural Killer Lytic-Associated Molecule (NKLAM) in Natural Killer Functi$337,500
R56 · FY2010 · AI · contact PI